BRIEF RESEARCH REPORT article
Front. Vet. Sci.
Sec. Animal Nutrition and Metabolism
Efficacy of Celastrol-Supplemented Diet in Overweight and Obese Dogs: A 24-Week Randomized Controlled Trial
Provisionally accepted
- 1Konkuk University, Seoul, Republic of Korea
- 2Veterinary Nutrition Laboratory, Jeil feed Co., Ltd, Daejeon, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Obesity is an increasingly common health issue among companion animals, contributing to various disorders and reduced life expectancy. Traditional management strategies such as caloric restriction and physical activity show limited long-term success, highlighting the need for alternative options. Celastrol, a leptin-sensitizing agent derived from Tripterygium wilfordii, has shown potent anti-obesity effects in rodent models; however, its effects in dogs have not been studied. This study evaluated the efficacy and safety of celastrol-supplemented feeding in overweight and obese dogs. Seventeen client-owned dogs (BCS ≥6) were randomly assigned to receive either a celastrol-supplemented diet or an isocaloric control diet for 24 weeks. Clinical parameters, including body weight, serum leptin concentrations, and physical activity were assessed at regular intervals. Dogs in the celastrol group exhibited a significantly greater reduction in body weight (mean 8.7%) compared to the control group (mean 2.1%) (p=0.003). Serum leptin concentrations also decreased more markedly in the celastrol group, although no significant group-by-time interaction was detected. No significant differences were found between groups in thoracic and abdominal girth, BCS, MCS, physical activity, or blood chemistry. Importantly, no adverse clinical events were observed, and blood chemistry remained within reference ranges, supporting systemic safety. These findings suggest that celastrol supplementation effectively promotes weight loss without evident safety concerns in overweight and obese dogs. The results provide preliminary in vivo evidence for celastrol's applicability in veterinary medicine and support its potential as an adjunctive strategy for obesity management. Further studies with larger and more diverse populations are warranted to validate these results.
Keywords: celastro1, companionanimals6, leptin4, obesity2, physical activity 5, weight management3
Received: 30 Sep 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Shin, Cho, Yoon and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: MuYoung Kim
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.